Treatment of atrial fibrillation in patients with enhanced sympathetic tone by pulmonary vein isolation or pulmonary vein isolation and renal artery denervation: clinical background and study design : The ASAF trial: ablation of sympathetic atrial fibrillation

Clinical Research in Cardiology : Official Journal of the German Cardiac Society
Mark R de JongArif Elvan

Abstract

Hypertension is an important, modifiable risk factor for the development of atrial fibrillation (AF). Even after pulmonary vein isolation (PVI), 20-40% experience recurrent AF. Animal studies have shown that renal denervation (RDN) reduces AF inducibility. One clinical study with important limitations suggested that RDN additional to PVI could reduce recurrent AF. The goal of this multicenter randomized controlled study is to investigate whether RDN added to PVI reduces AF recurrence. The main end point is the time until first AF recurrence according to EHRA guidelines after a blanking period of 3 months. Assuming a 12-month accrual period and 12 months of follow-up, a power of 0.80, a two-sided alpha of 0.05 and an expected drop-out of 10% per group, 69 patients per group are required. We plan to randomize a total of 138 hypertensive patients with AF and signs of sympathetic overdrive in a 1:1 fashion. Patients should use at least two antihypertensive drugs. Sympathetic overdrive includes obesity, exercise-induced excessive blood pressure (BP) increase, significant white coat hypertension, hospital admission or fever induced AF, tachycardia induced AF and diabetes mellitus. The interventional group will undergo PVI + RDN and t...Continue Reading

References

Jul 10, 2002·Journal of the American College of Cardiology·Paul A SmithDavid A S G Mary
Aug 28, 2009·The New England Journal of Medicine·Markus P SchlaichMurray D Esler
Sep 3, 2011·Journal of the American College of Cardiology·Christian UkenaMichael Böhm
Apr 4, 2012·Journal of Hypertension·Roland E SchmiederCostas Tsioufis
May 19, 2012·Journal of the American Society of Nephrology : JASN·Dagmara HeringMarkus P Schlaich
May 29, 2012·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Ann-Kathrin ZieglerStefan C Bertog
Jul 19, 2012·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Benjamin KaltenbachHorst Sievert
Aug 8, 2012·Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing·Qingyan ZhaoCongxin Huang
Aug 28, 2012·Lancet·Oliver VonendDirk Blondin
Oct 16, 2012·Journal of the American College of Cardiology·Mathias C BrandtUta C Hoppe
Nov 7, 2012·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Arif ElvanMaurits A Allessie
Sep 26, 2013·Journal of the American College of Cardiology·Jan A StaessenSverre Kjeldsen
Dec 24, 2013·Blood Pressure·Giuseppe ManciaFaiez Zannad
May 27, 2014·Journal of the American College of Cardiology·George L BakrisUNKNOWN SYMPLICITY HTN-3 Investigators

❮ Previous
Next ❯

Citations

Nov 11, 2018·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Lida FeyzJoost Daemen
Mar 10, 2020·Circulation·Mina K ChungUNKNOWN American Heart Association Electrocardiography and Arrhythmias Committee and Exercise, Cardiac Rehabilitation, and Secondary
Sep 27, 2019·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Christian UkenaMichael Böhm
Jun 15, 2019·Nature Reviews. Cardiology·Neil HerringDavid J Paterson
Jul 8, 2019·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Paweł T MatusikAnetta Undas

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.